An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a forum is saying they tried higher-dose Wegovy (a brand of semaglutide) for a couple of months and didn’t lose weight — in fact they put on weight and feel hungrier some days. They say they went from a 1.5 mg pill to 4 mg for a month each, track calories around 1,500 a day, do cardio a few times a week, and were approved to try 9 mg next month but are discouraged because they haven’t seen results. Wegovy is the brand name for a drug whose active ingredient is semaglutide. Semaglutide is a man-made copy of a natural hormone your gut releases after eating that helps signal fullness to your brain and slows how fast your stomach empties. Doctors use it to help people lose weight by reducing appetite and supporting lower calorie intake over time. It’s usually given by prescription and, depending on the plan, the dose is gradually increased under medical supervision. This report is an individual’s experience — an anecdote, not a scientific study. Clinical trials of semaglutide showed average weight loss for many participants, but not everyone responds the same way. A month at a given dose can be too short to see full effects; semaglutide often takes several weeks to build effect and some people need a few months or dose adjustments. Also, real-world results vary because of differences in biology, other medications, stress, sleep, eating patterns, and how strictly calories are tracked. The person reports tracking 1,500 calories and exercising, but self-reported calorie counts can be off, and temporary weight fluctuations (water, muscle, menstrual cycles, inflammation) can mask early fat loss. Why this matters: if you or someone you know is considering GLP-1 drugs like Wegovy or already on them, this highlights that they’re not an instant fix and don’t work the same for everyone. It’s useful for setting expectations: some people get strong appetite suppression and steady weight loss; others see little change, plateaus, or even temporary weight gain. If the medication isn’t doing what was hoped, it’s worth talking with the prescribing clinician before changing doses. They can review other factors, check for interactions with other drugs, consider medical causes of weight gain, and decide whether to keep increasing the dose or try a different approach. Important caveats: this is one person’s story, not a controlled trial. Semaglutide can cause side effects like nausea, vomiting, constipation, or more rarely serious issues; dose increases are usually done slowly to reduce side effects. Some people shouldn’t take it (for example, those with certain hormone-related cancers or a history of pancreatitis), and insurance coverage and regulatory approvals vary by country and dose. If weight is going in the wrong direction or appetite and symptoms change, a medical check-up is the right step rather than self-adjusting doses. Bottom line: one person’s lack of early response to Wegovy doesn’t mean the drug won’t work for others — but it’s a reminder that effects vary, progress can be slow, and medical follow-up is important before making changes.
Source: r/Semaglutide